Literature DB >> 10928282

Developmental motoneuron cell death and neurotrophic factors.

M Sendtner1, G Pei, M Beck, U Schweizer, S Wiese.   

Abstract

During the development of higher vertebrates, motoneurons are generated in excess. In the lumbar spinal cord of the developing rat, about 6000 motoneurons are present at embryonic day 14. These neurons grow out axons which make contact with their target tissue, the skeletal muscle, and about 50% of the motoneurons are lost during a critical period from embryonic day 14 until postnatal day 3. This process, which is called physiological motoneuron cell death, has been the focus of research aiming to identify neurotrophic factors which regulate motoneuron survival during this developmental period. Motoneuron cell death can also be observed in vitro when the motoneurons are isolated from the embryonic avian or rodent spinal cord. These isolated motoneurons and other types of primary neurons have been a useful tool for studying basic mechanisms underlying neuronal degeneration during development and under pathophysiological conditions in neurodegenerative disorders. Accumulating evidence from such studies suggests that some specific requirements of motoneurons for survival and proper function may change during development. The focus of this review is a synopsis of recent data on such specific mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928282     DOI: 10.1007/s004410000217

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  34 in total

1.  Motoneuron programmed cell death in response to proBDNF.

Authors:  Anna R Taylor; David J Gifondorwa; Mac B Robinson; Jane L Strupe; David Prevette; James E Johnson; Barbara Hempstead; Ronald W Oppenheim; Carolanne E Milligan
Journal:  Dev Neurobiol       Date:  2012-05       Impact factor: 3.964

2.  Astrocyte and muscle-derived secreted factors differentially regulate motoneuron survival.

Authors:  Anna R Taylor; David J Gifondorwa; Jason M Newbern; Mac B Robinson; Jane L Strupe; David Prevette; Ronald W Oppenheim; Carolanne E Milligan
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  Neurotrophin expression in neural stem cells grafted acutely to transected spinal cord of adult rats linked to functional improvement.

Authors:  Ying-Li Gu; Lu-Wei Yin; Zhuo Zhang; Jia Liu; Su-Juan Liu; Lian-Feng Zhang; Ting-Hua Wang
Journal:  Cell Mol Neurobiol       Date:  2012-05-10       Impact factor: 5.046

5.  Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse.

Authors:  Jin Yu; Hong Zhu; Dorothy Ko; Mark S Kindy
Journal:  Brain Res       Date:  2008-08-29       Impact factor: 3.252

6.  Optimized methods for rapidly dissecting spinal cords and harvesting spinal motor neurons with high survival and purity from rats at different embryonic stages.

Authors:  Shudong Chen; Ruimin Tian; Hui Li; Meihui Chen; Hu Zhang; Dingkun Lin
Journal:  J Spinal Cord Med       Date:  2017-05-25       Impact factor: 1.985

Review 7.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.

Authors:  G Yacila; Y Sari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

9.  High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Mol Neurodegener       Date:  2010-04-21       Impact factor: 14.195

10.  G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice.

Authors:  Alexandre Henriques; Claudia Pitzer; Luc Dupuis; Armin Schneider
Journal:  BMC Neurosci       Date:  2010-02-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.